Indian Patent Office rejects AbbVie patent bid for cancer drug Venetoclax; generics may enter market
The Indian Patent Office rejected AbbVie’s patent application for cancer drug Venetoclax (Venclexta), a decision expected to ease the entry of lower-cost generics.
Emilio Berkenwald of Berken IP examines Argentina’s continued absence from the Patent Cooperation Treaty, the practical ...
Dr. Alex is one of the most experienced rubber technologists in India. We are extremely fortunate to be able to draw on ...
A significant milestone in this sector was reached recently as a prominent China Polyurethane Acrylate Oligomer Factory, ...
WTR is a unique and timely intelligence service informing commercial trademark decision making by assessing the business impact of trademark law developments.
Independent evaluation explores patent-pending pressurized air throat hit technology, no-heat no-vapor valve mechanism, third ...
And while not every company can put the same level of dollars toward building and growing a brand as global corporations, any business that has invested time and money into its name has a reason to ...
U.S. restrictions on visas and growing uncertainty for international students and skilled workers, contrasted with China’s ...
Competitive universities seek to understand who a student is, how they think, what they value, and whether their interests ...
Discusses Leadership Transition and Strategic Vision for Future Growth January 23, 2026 10:00 AM ESTCompany ParticipantsPatrick Gruber ...
A new laser-based manufacturing platform enables high-speed, high-precision metallisation directly on complex 3D parts, opening fresh design possibilities beyond flat PCBs.
The case examined whether the Assessing Officer could reject a DCF valuation. The Tribunal held that commercial valuation choices, if legally prescribed and supported, cannot be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results